These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18499891)

  • 1. Oncostatin M-mediated regulation of KIT-ligand-induced extracellular signal-regulated kinase signaling maintains hematopoietic repopulating activity of Lin-CD34+CD133+ cord blood cells.
    Oostendorp RA; Gilfillan S; Parmar A; Schiemann M; Marz S; Niemeyer M; Schill S; Hammerschmid E; Jacobs VR; Peschel C; Götze KS
    Stem Cells; 2008 Aug; 26(8):2164-72. PubMed ID: 18499891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34(+) cells after ex vivo expansion.
    Danet GH; Lee HW; Luongo JL; Simon MC; Bonnet DA
    Exp Hematol; 2001 Dec; 29(12):1465-73. PubMed ID: 11750106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haematopoietic repopulating activity in human cord blood CD133+ quiescent cells.
    Boxall SA; Cook GP; Pearce D; Bonnet D; El-Sherbiny YM; Blundell MP; Howe SJ; Leek JP; Markham AF; de Wynter EA
    Bone Marrow Transplant; 2009 Apr; 43(8):627-35. PubMed ID: 18997827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD133-enriched CD34(-) (CD33/CD38/CD71)(-) cord blood cells acquire CD34 prior to cell division and hematopoietic activity is exclusively associated with CD34 expression.
    Götze KS; Schiemann M; Marz S; Jacobs VR; Debus G; Peschel C; Oostendorp RA
    Exp Hematol; 2007 Sep; 35(9):1408-14. PubMed ID: 17656010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FLK-2/FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver.
    Muench MO; Roncarolo MG; Menon S; Xu Y; Kastelein R; Zurawski S; Hannum CH; Culpepper J; Lee F; Namikawa R
    Blood; 1995 Feb; 85(4):963-72. PubMed ID: 7531516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of CFU-GM, BFU-E and endothelial progenitor cells using ex vivo expansion of selected cord blood CD133(+) and CD34(+) cells.
    Lu X; Baudouin SV; Gillespie JI; Anderson JJ; Dickinson AM
    Cytotherapy; 2007; 9(3):292-300. PubMed ID: 17464761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors.
    de Wynter EA; Buck D; Hart C; Heywood R; Coutinho LH; Clayton A; Rafferty JA; Burt D; Guenechea G; Bueren JA; Gagen D; Fairbairn LJ; Lord BI; Testa NG
    Stem Cells; 1998; 16(6):387-96. PubMed ID: 9831864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient adenoviral vector transduction of human hematopoietic SCID-repopulating and long-term culture-initiating cells.
    Fan X; Brun A; Segrén S; Jacobsen SE; Karlsson S
    Hum Gene Ther; 2000 Jun; 11(9):1313-27. PubMed ID: 10890741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of growth factor conditions that reduce ex vivo cord blood progenitor expansion but do not alter human repopulating cell function in vivo.
    Levac K; Karanu F; Bhatia M
    Haematologica; 2005 Feb; 90(2):166-72. PubMed ID: 15710567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells.
    Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L
    J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
    Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
    J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel subpopulation of human cord blood CD34-CD133-CD7-CD45+lineage- cells capable of lymphoid/NK cell differentiation after in vitro exposure to IL-15.
    Rutella S; Bonanno G; Marone M; De Ritis D; Mariotti A; Voso MT; Scambia G; Mancuso S; Leone G; Pierelli L
    J Immunol; 2003 Sep; 171(6):2977-88. PubMed ID: 12960322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly efficient ex vivo expansion of human hematopoietic stem cells using Delta1-Fc chimeric protein.
    Suzuki T; Yokoyama Y; Kumano K; Takanashi M; Kozuma S; Takato T; Nakahata T; Nishikawa M; Sakano S; Kurokawa M; Ogawa S; Chiba S
    Stem Cells; 2006 Nov; 24(11):2456-65. PubMed ID: 16857897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on the dynamics of biological characteristics of CD133+ cells from human umbilical cord blood during short-term culture].
    Hao SG; Sun GL; Wu WL; Wu YL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):569-75. PubMed ID: 14706136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of megakaryocyte precursors and stem cells from umbilical cord blood CD34+ cells in collagen and liquid culture media.
    Shaw PH; Olszewski M; Kletzel M
    J Hematother Stem Cell Res; 2001 Jun; 10(3):391-403. PubMed ID: 11454314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncostatin M regulates SOCS3 mRNA stability via the MEK-ERK1/2-pathway independent of p38(MAPK)/MK2.
    Ehlting C; Böhmer O; Hahnel MJ; Thomas M; Zanger UM; Gaestel M; Knoefel WT; Schulte Am Esch J; Häussinger D; Bode JG
    Cell Signal; 2015 Mar; 27(3):555-67. PubMed ID: 25562430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential modulation of adhesion markers with ex vivo expansion of human umbilical CD34+ progenitor cells.
    Reems JA; Mielcarek M; Torok-Storb B
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):133-41. PubMed ID: 9310190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human CD34+ CD133+ hematopoietic stem cells cultured with growth factors including Angptl5 efficiently engraft adult NOD-SCID Il2rγ-/- (NSG) mice.
    Drake AC; Khoury M; Leskov I; Iliopoulou BP; Fragoso M; Lodish H; Chen J
    PLoS One; 2011 Apr; 6(4):e18382. PubMed ID: 21559522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of long-term repopulating potential of human cord blood-derived CD34-flt3- severe combined immunodeficiency-repopulating cells by intra-bone marrow injection.
    Kimura T; Asada R; Wang J; Kimura T; Morioka M; Matsui K; Kobayashi K; Henmi K; Imai S; Kita M; Tsuji T; Sasaki Y; Ikehara S; Sonoda Y
    Stem Cells; 2007 Jun; 25(6):1348-55. PubMed ID: 17303816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia improves expansion potential of human cord blood-derived hematopoietic stem cells and marrow repopulation efficiency.
    Roy S; Tripathy M; Mathur N; Jain A; Mukhopadhyay A
    Eur J Haematol; 2012 May; 88(5):396-405. PubMed ID: 22268587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.